Comments
GSK and J&J lead rivals in drug access for poor
28.11.2012. | LONDON (Reuters) - Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being attacked in the past for not doing enough....
